Literature DB >> 29894742

Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.

Carolina Lagos1, Patricia Carvajal1, Isabel Castro2, Daniela Jara1, Sergio González3, Sergio Aguilera4, María-José Barrera1, Andrew F G Quest1, Verónica Bahamondes2, Claudio Molina5, Ulises Urzúa6, Marcela A Hermoso7, Cecilia Leyton2, María-Julieta González8.   

Abstract

Here, we determined the 5-hydroxymethylcytosine (5hmC), 5-methylcytosine (5mC), Ten Eleven Translocation (TETs), and DNA methyltransferases (DNMTs) levels in epithelial and inflammatory cells of labial salivary glands (LSG) from Sjögren's syndrome (SS)-patients and the effect of cytokines on HSG cells. LSG from SS-patients, controls and HSG cells incubated with cytokines were analysed. Levels of 5mC, 5hmC, DNMTs, TET2 and MeCP2 were assessed by immunofluorescence. In epithelial cells from SS-patients, an increase in TET2, 5hmC and a decrease in 5mC and MeCP2 were observed, additionally, high levels of 5mC and DNMTs and low levels of 5hmC were detected in inflammatory cells. Cytokines increased TET2 and 5hmC and decreased 5mC levels. Considering that the TET2 gene.promoter contains response elements for transcription factors activated by cytokines, together to in vitro results suggest that changes in DNA hydroxymethylation, resulting from altered levels of TET2 are likely to be relevant in the Sjögren's syndrome etiopathogenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-hydroxymethylcytosine; Global DNA methylation; Pro-inflammatory cytokines; Sjögren's syndrome; TET2

Mesh:

Substances:

Year:  2018        PMID: 29894742     DOI: 10.1016/j.clim.2018.06.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

1.  DNA Methyltransferase 1 Is Dysregulated in Parkinson's Disease via Mediation of miR-17.

Authors:  Hong-Qiu Zhang; Jian-Yong Wang; Zhao-Feng Li; Lei Cui; Shi-Shi Huang; Lan-Bing Zhu; Yue Sun; Rui Yang; Hui-Hui Fan; Xiong Zhang; Jian-Hong Zhu
Journal:  Mol Neurobiol       Date:  2021-01-22       Impact factor: 5.590

Review 2.  JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.

Authors:  Amandine Charras; Pinelopi Arvaniti; Christelle Le Dantec; Marina I Arleevskaya; Kaliopi Zachou; George N Dalekos; Anne Bordon; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

Review 3.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

4.  Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4+ T cells in systemic sclerosis via IRF1 signaling.

Authors:  Yaqian Shi; Rong Xiao; Zhuotong Zeng; Yaoyao Wang; Yangfan Xiao; Jie Zheng; Ruizhen Liu; Xinglan He; Jiangfan Yu; Bingsi Tang; Xiangning Qiu; Rui Tang
Journal:  Arthritis Res Ther       Date:  2022-02-19       Impact factor: 5.156

5.  Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.

Authors:  Isabel Castro; Patricia Carvajal; Daniela Jara; Sergio Aguilera; Benjamín Heathcote; María-José Barrera; Víctor Aliaga-Tobar; Vinicius Maracaja-Coutinho; Ulises Urzúa; Andrew F G Quest; Sergio González; Claudio Molina; Marcela Hermoso; María-Julieta González
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 6.  Role of Tet2 in Regulating Adaptive and Innate Immunity.

Authors:  Jiaqi Li; Lifang Li; Xiaoxiao Sun; Tuo Deng; Gan Huang; Xia Li; Zhiguo Xie; Zhiguang Zhou
Journal:  Front Cell Dev Biol       Date:  2021-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.